EUCTR2012-002547-15-ES进行中（未招募）不适用
TILITY OF THE ocolytict MAINTENANCE TREATMENT IN THE MANAGEMENT OF THE THREAT OF PREMATURE
Instituto de Investigacion Sanitaria La Fe0 个研究点开始时间: 2012年9月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women with singleton pregnancies with intact membranes have passed an episode of APP (uterine contractions with cervical change) successfully treated with acute tocolysis with atosiban. Cervical length ? 25 mm
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
- •Women with singleton pregnancies with intact membranes have passed an episode of APP (uterine contractions with cervical change) successfully treated with acute tocolysis with atosiban. Cervical length ? 25 mm
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Cervical dilation ? 3 cm, multiple gestation, maternal medical contraindication to tocolysis with nifedipine, atosiban or progesterone, or obstetric contraindication to tocolytic therapy (severe preeclampsia, intrauterine infection, placental abruption, fetal anomaly incompatible with life, fetal death).
- •Cervical dilation ? 3 cm, multiple gestation, maternal medical contraindication to tocolysis with nifedipine, atosiban or progesterone, or obstetric contraindication to tocolytic therapy (severe preeclampsia, intrauterine infection, placental abruption, fetal anomaly incompatible with life, fetal death).
研究者
相似试验
已完成
1 期
Safety Evaluation of the Maintenance treatment of Sorafenib in Hepatocellular carcinoma patients with Tumor thrombus after palliative surgeryTo evaluate the safety of sorafenib as a maintenance therapy after the surgical resection of hepatocellular carcinoma (HCC) with macroscopic vascular invasion (Vp, Vv, B).JPRN-UMIN000005910Tokyo University Hospital12
进行中（未招募）
不适用
MAINTENANCE PHASE STUDY” A THERAPEUTIC EQUIVALENCE STUDY COMPARING THE EFFICACY AND SAFETY OF INTRAVENOUS EPOETIN (PLIVA) AND EPOETIN ALFA (JANSSEN CILAG) IN PATIENTS WITH CHRONIC RENAL FAILURE REQUIRING HEMODIALYSIS AND RECEIVING EPOETIN MAINTENANCE TREATMENT A multinational, multicenter, randomized, comparator controlled, parallel-group, double blind phase III studyEUCTR2005-003302-28-LTPLIVA Research and Development Ltd.256
已完成
不适用
Study of the efficacy and safety of maintenance Irinotecan in patients with extended small cell lung cancer after 4 courses of Cisplatin plus Irinotecan chemotherapy.JPRN-UMIN000008821Division of Thoracic Oncology, National Cancer Center Hospital East28
尚未招募
2 期
ow dose Capecitabine in Triple Negative Breast Cancer patients as maintenance in Indian WomeCTRI/2023/06/054056Maharishi Markandeshwar Institute of Medical Sciences and Research Centre
已完成
不适用
The study of the effectiveness of maintenance treatment with infliximab for ulcerative colitis patients who respond to induction treatment with infliximabulcerative colitisJPRN-UMIN000007341Tohoku University Graduate School of Medicine (Tohoku University Hospital)90